UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000011174 |
|---|---|
| Receipt number | R000013091 |
| Scientific Title | A randomized Phase II study of Carboplatin + Pemetrexed followed by Pemetrexed versus Carboplatin+Pemetrexed followed by Erlotinib in patients with advanced Non-squamous and Non- Small Cell Lung Cancer with EGFR sensitive mutations LOGIK1302- |
| Date of disclosure of the study information | 2013/07/11 |
| Last modified on | 2021/01/14 09:48:52 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2013/07/11 17:24:24 | ||
| 2 | Update | 2013/07/16 14:31:26 | Institutions |
|
| 3 | Update | 2013/10/25 10:12:11 | Recruitment status |
|
| 4 | Update | 2013/10/25 10:16:34 | Email |
|
| 5 | Update | 2014/09/09 10:01:08 | Institute |
|
| 6 | Update | 2015/01/13 13:40:38 | Public title |
|
| 7 | Update | 2016/01/12 09:11:08 | Randomization unit Interventions/Control_1 Interventions/Control_2 |
|
| 8 | Update | 2016/01/12 09:11:47 | Recruitment status |
|
| 9 | Update | 2018/01/15 09:40:17 | Name of primary person or sponsor Organization |
|
| 10 | Update | 2021/01/14 09:48:52 | Recruitment status Date of IRB |
